High Plasma Oxalate Levels Early After Kidney Transplantation Are Associated With Impaired Long-Term Outcomes.

Elevated levels of oxalate are common in renal failure patients and non-hyperoxaluria disease, and may cause damage after transplantation. We examined outcomes after 15 years for 167 kidney transplant recipients who had plasma oxalate measured early after transplantation. Analyses included plasma oxalate, recipient age, donor age, live donor, HLA-DR mismatch, mGFR, and smoking. Median age was 52 years (range 18-81), 63% were male and 38% had live donors. Median plasma oxalate concentration 10 weeks after transplantation was 9.0 μmol/L (range 2.7-53.0), one third above the upper reference limit (11.0 μmol/L). Multivariable analysis revealed upper quartile plasma oxalate (>13.0 μmol/L, = 0.008), recipient age ( < 0.001), deceased donor ( = 0.003), and current smoking ( < 0.001) as significant factors associated with patient survival. Upper quartile plasma oxalate ( = 0.021), recipient age ( = 0.001), deceased donor kidney ( = 0.001), HLA-DR mismatch ( = 0.015), and current smoking ( = 0.014) were also associated with graft loss. Factors associated with death censored graft losses were donor age ( = 0.012), deceased donor ( = 0.032), and HLA-DR mis-matched kidneys ( = 0.005) but plasma oxalate was not ( = 0.188). Plasma oxalate in the upper quartile early after transplantation was significantly associated with impaired long-term patient survival and graft losses, but not when censored for death.